Statistics for Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial
Total visits
views | |
---|---|
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial | 54 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:6af2d4f9-9047-461d-9343-a2c297a5df84 | 5 |
java.util.UUID:0919802d-7856-4dcc-822d-bef420902a3c | 1 |
Top country views
views | |
---|---|
United States | 45 |
China | 2 |
Germany | 2 |
Top city views
views | |
---|---|
Wilmington | 37 |
Ann Arbor | 3 |
Baltimore | 2 |
Gunzenhausen | 2 |
Washington | 2 |
Tustin | 1 |